ArticleScience advances2021

Self-assembling synthetic nanoadjuvant scaffolds cross-link B cell receptors and represent new platform technology for therapeutic antibody production.

Sujata Senapati et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.